Nick Gebruers1,2,3, Melissa Camberlin4, Fleur Theunissen4, Wiebren Tjalma5,6,7, Hanne Verbelen4, Timia Van Soom4, Eric van Breda4. 1. Department of Rehabilitation Sciences and Physiotherapy REVAKI-MOVANT Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium. nick.gebruers@uantwerpen.be. 2. Multidisciplinary Breast Clinic, Antwerp University Hospital, Antwerp, Belgium. nick.gebruers@uantwerpen.be. 3. Multidisciplinary Edema Clinic, Antwerp University Hospital, Antwerp, Belgium. nick.gebruers@uantwerpen.be. 4. Department of Rehabilitation Sciences and Physiotherapy REVAKI-MOVANT Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium. 5. Multidisciplinary Breast Clinic, Antwerp University Hospital, Antwerp, Belgium. 6. Multidisciplinary Edema Clinic, Antwerp University Hospital, Antwerp, Belgium. 7. Department of Medicine, University of Antwerp, Antwerp, Belgium.
Abstract
OBJECTIVES: The primary purpose of this systematic review is to structure the available evidence concerning physical exercise programs and their effects on (1) physical performance outcomes, (2) experienced fatigue, and (3) quality of life (QoL) in patients during the initial treatment for breast cancer. DATA SOURCES: A systematic literature search, based upon the PRISMA guideline, up to January 1, 2018, was performed using four databases (Web of Science, Cochrane Library for Clinical Trials, PubMed, and Medline). STUDY SELECTION: Inclusion criteria were as follows: (1) adults > 18 years; (2) patients with breast cancer undergoing initial treatment; (3) interventions with the aim to influence the patient's physical activity, QoL, or fatigue; (4) randomized controlled trials (RCTs) of all ages. The selected studies were scored for methodological quality, and data concerning physical performance, QoL, and fatigue were extracted. Twenty-eight RCTs were included. DATA EXTRACTION: Different treatment modalities during initial treatment were identified (radiation therapy, chemotherapy, and combination therapy), as well as different types of physical training interventions (cardiovascular endurance exercise, strengthening programs, or a combination of both). Therefore, the results were clustered with regard to the above-mentioned grouping; extracting every relevant outcome related to physical performance (6 MWT or VO2peak; grip/muscle strength), QoL (questionnaires), and fatigue (questionnaires). DATA SYNTHESIS: Different training programs (endurance, resistance, or a combination of both) were found. These programs were applied during different phases of initial treatment. Some programs were supervised while others were home based. Overall, most training interventions provided an improvement in physical performance and a decrease in perceived fatigue. QoL was the outcome variable least susceptible to improvement. CONCLUSION: Different types of exercise programs are available for rehabilitation purposes of breast cancer patients during adjuvant therapy. Overall resistance training or resistance training in combination with CV endurance training provides the best results, especially on physical performance and perceived fatigue.
OBJECTIVES: The primary purpose of this systematic review is to structure the available evidence concerning physical exercise programs and their effects on (1) physical performance outcomes, (2) experienced fatigue, and (3) quality of life (QoL) in patients during the initial treatment for breast cancer. DATA SOURCES: A systematic literature search, based upon the PRISMA guideline, up to January 1, 2018, was performed using four databases (Web of Science, Cochrane Library for Clinical Trials, PubMed, and Medline). STUDY SELECTION: Inclusion criteria were as follows: (1) adults > 18 years; (2) patients with breast cancer undergoing initial treatment; (3) interventions with the aim to influence the patient's physical activity, QoL, or fatigue; (4) randomized controlled trials (RCTs) of all ages. The selected studies were scored for methodological quality, and data concerning physical performance, QoL, and fatigue were extracted. Twenty-eight RCTs were included. DATA EXTRACTION: Different treatment modalities during initial treatment were identified (radiation therapy, chemotherapy, and combination therapy), as well as different types of physical training interventions (cardiovascular endurance exercise, strengthening programs, or a combination of both). Therefore, the results were clustered with regard to the above-mentioned grouping; extracting every relevant outcome related to physical performance (6 MWT or VO2peak; grip/muscle strength), QoL (questionnaires), and fatigue (questionnaires). DATA SYNTHESIS: Different training programs (endurance, resistance, or a combination of both) were found. These programs were applied during different phases of initial treatment. Some programs were supervised while others were home based. Overall, most training interventions provided an improvement in physical performance and a decrease in perceived fatigue. QoL was the outcome variable least susceptible to improvement. CONCLUSION: Different types of exercise programs are available for rehabilitation purposes of breast cancerpatients during adjuvant therapy. Overall resistance training or resistance training in combination with CV endurance training provides the best results, especially on physical performance and perceived fatigue.
Entities:
Keywords:
Benefit; Breast cancer; Breast neoplasm; Fatigue; Motor activity; Physical activity; QoL
Authors: Lianne B Dolan; Karen Gelmon; Kerry S Courneya; John R Mackey; Roanne J Segal; Kirstin Lane; Robert D Reid; Donald C McKenzie Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-09-22 Impact factor: 4.254
Authors: Mick Van de Wiel; Yanina Dockx; Tim Van den Wyngaert; Sigrid Stroobants; Wiebren A A Tjalma; Manon T Huizing Journal: Eur J Obstet Gynecol Reprod Biol Date: 2016-12-14 Impact factor: 2.435
Authors: Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman Journal: Lancet Date: 2014-11-26 Impact factor: 79.321
Authors: Victoria Mock; Constantine Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry J Stewart; Lane Cameron; Kristin Zawacki; Laura J Podewils; Gary Cohen; Ruth McCorkle Journal: Psychooncology Date: 2005-06 Impact factor: 3.894
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: V Mock; M B Burke; P Sheehan; E M Creaton; M L Winningham; S McKenney-Tedder; L P Schwager; M Liebman Journal: Oncol Nurs Forum Date: 1994-06 Impact factor: 2.172
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Kerry S Courneya; Roanne J Segal; Karen Gelmon; Robert D Reid; John R Mackey; Christine M Friedenreich; Caroline Proulx; Kirstin Lane; Aliya B Ladha; Jeffrey K Vallance; Qi Liu; Yutaka Yasui; Donald C McKenzie Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254
Authors: Sine Rossen; Karen Trier; Berit Christensen; Martina A Eriksen; Ann-Dorthe Zwisler; Jette Vibe-Petersen Journal: Support Care Cancer Date: 2019-08-02 Impact factor: 3.603
Authors: Salvatore Ficarra; Ewan Thomas; Antonino Bianco; Ambra Gentile; Petra Thaller; Fulvio Grassadonio; Sofia Papakonstantinou; Thorsten Schulz; Nils Olson; Alexandra Martin; Christian Wagner; Anna Nordström; Hande Hofmann Journal: Breast Cancer Date: 2022-03-12 Impact factor: 3.307